Verdura, S.; Encinar, J.A.; Fernández-Arroyo, S.; Joven, J.; Cuyà s, E.; Bosch-Barrera, J.; Menendez, J.A.
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells. Int. J. Mol. Sci. 2022, 23, 9986.
https://doi.org/10.3390/ijms23179986
AMA Style
Verdura S, Encinar JA, Fernández-Arroyo S, Joven J, Cuyàs E, Bosch-Barrera J, Menendez JA.
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells. International Journal of Molecular Sciences. 2022; 23(17):9986.
https://doi.org/10.3390/ijms23179986
Chicago/Turabian Style
Verdura, Sara, José Antonio Encinar, Salvador Fernández-Arroyo, Jorge Joven, Elisabet Cuyà s, Joaquim Bosch-Barrera, and Javier A. Menendez.
2022. "Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells" International Journal of Molecular Sciences 23, no. 17: 9986.
https://doi.org/10.3390/ijms23179986
APA Style
Verdura, S., Encinar, J. A., Fernández-Arroyo, S., Joven, J., Cuyà s, E., Bosch-Barrera, J., & Menendez, J. A.
(2022). Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells. International Journal of Molecular Sciences, 23(17), 9986.
https://doi.org/10.3390/ijms23179986